Who is sponsoring NCT04326543?

NCT04326543 is sponsored by Università degli Studi di Sassari.

What condition does NCT04326543 study?

NCT04326543 studies Attention Deficit Hyperactivity Disorder.

Is NCT04326543 still recruiting?

NCT04326543 is currently completed. Last updated 30 March 2020.

Last reviewed 2020-03-30 · How we verify

NCT04326543

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Temperament Dimensions and Awakening Salivary Cortisol Levels in ADHD.

Completed Last updated 30 March 2020

What this trial tests

trial testing Swanson, Noolan and Phelham - IV edition (SNAP-IV); Conners' Parent Rating Scales (CPRS) in Attention Deficit Hyperactivity Disorder in 120 participants. Completed in 12 January 2018.

Timeline

18 January 2017

Primary endpoint
29 September 2017

12 January 2018

Quick facts

Lead sponsor	Università degli Studi di Sassari
Status	Completed
Study type	OBSERVATIONAL
Enrollment	120
Start date	18 January 2017
Primary completion	29 September 2017
Estimated completion	12 January 2018
Sites	2 locations across Italy

Drugs / interventions tested

Swanson, Noolan and Phelham - IV edition (SNAP-IV); Conners' Parent Rating Scales (CPRS)

Conditions studied

Attention Deficit Hyperactivity Disorder — all drugs for Attention Deficit Hyperactivity Disorder →

Sponsor

Università degli Studi di Sassari

Who can join

Adults 3 to 16, any sex, with Attention Deficit Hyperactivity Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To analyze heterogeneity in ADHD experts in last decade advised to look beyond the lists of existing symptoms towards phenotypic measures that can be represented dimensionally and have well-theorized relationships with neurobiological systems, (Sonuga-Barke \& Halperin, 2010; Insel et al, 2010; Fair D, Bathula D, Nikolas M, Nigg JT, 2012; Georgiades S, Szatmari P, Boyle M, 2013; Sanislow CA, Pine DS, Quinn KJ, et al, 2013). This is the nucleus of RDoC aims because children and adolescents with ADHD can be characterized in terms of several features that are best represented as dimensions and have well-theorized relationships to biological systems (Cuthbert \& Insel, 2013).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Temperament Dimensions and Awakening Cortisol Levels in Attention-Deficit/Hyperactivity Disorder.
Carta A, Vainieri I, Rommel AS, Zuddas A, et al · · 2022 · cited 4× · PMID 35546956 · DOI 10.3389/fpsyt.2022.803001

Verify or expand the search:

Other recruiting trials for Attention Deficit Hyperactivity Disorder

Currently open trials in the same condition.

NCT07001475 — A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperact · Phase 1 · recruiting
NCT06847165 — Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure · NA · recruiting
NCT06325813 — ADHD PreSMA Response Inhibition Therapy · NA · recruiting
NCT06248229 — A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder · Phase 4 · recruiting
NCT06232226 — Attention Deficit Hyperactivity Disorder · NA · recruiting

Other Università degli Studi di Sassari trials

Trials by the same sponsor.

NCT06276712 — RCT Comparing KS Versus TS for Ovedenture · NA · not yet recruiting
NCT06286579 — SOI Immediately vs Delayed · NA · not yet recruiting
NCT06286605 — RCT GBR One Stages Comparing A-Oss and Autogenous Bone Versus A-Oss and LCR-A · NA · not yet recruiting
NCT06286566 — Soi TS3 Surface in Patients With and Without Type 2 Diabetes · NA · not yet recruiting
NCT05843981 — Comparison KS Versus TS · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04326543 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Università degli Studi di Sassari
Last refreshed: 30 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04326543.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing